Autophagy publishes peer-reviewed research on all aspects of autophagic processes.
The aim of Autophagy is to be the premiere journal publishing high quality papers in the field which has advanced tremendously, due in large part to the multiple connections between autophagy and various aspects of human health and disease.
Autophagy covers the following topics: autophagic processes (i.e. the lysosome/vacuole dependent degradation of intracellular material); the connections between autophagy and various aspects of human health and disease including, cancer, neurodegeneration, aging, diabetes, myopathies and heart disease; and we are interested in all experimental systems, from yeast to human. Suggestions for appropriate specialized topics are welcome.
The journal accepts the following article types:
Original research (basic science, translational and clinical)
Reviews (both comprehensive overviews and short puncta)
35 days avg. from submission to first
post-review decision
14 days avg. from acceptance to online
publication
31% acceptance rate
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors
who are deciding where to submit their next manuscript for publication.
However, any one metric only tells a part of the story of a journal’s
quality and impact. Each metric has its limitations which means that it
should never be considered in isolation, and metrics should be used to
support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside
other qualitative factors such as a journal’s aims & scope, its
readership, and a review of past content published in the journal. In
addition, a single article should always be assessed on its own merits and
never based on the metrics of the journal it was published in.
Usage and acceptance rate data above are for the last full calendar year
and are updated annually in February. Speed data is updated every six
months, based on the prior six months. Citation metrics are updated
annually mid-year. Please note that some journals do not display all of
the following metrics
(find out why).
Usage:
the total number of times articles in the journal were viewed by users
of Taylor & Francis Online in the previous calendar year, rounded to the
nearest thousand.
Citation Metrics
Impact Factor*:
the average number of citations received by articles published in the
journal within a two-year window. Only journals in the Clarivate Science
Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI),
Arts and Humanities Citation Index (AHCI) and the Emerging Sources
Citation Index (ESCI) have an Impact Factor.
Impact Factor Best Quartile*:
the journal’s highest subject category ranking in the Journal Citation
Reports. Q1 = 25% of journals with the highest Impact Factors.
5 Year Impact Factor*:
the average number of citations received by articles in the journal
within a five-year window.
CiteScore (Scopus)†:
the average number of citations received by articles in the journal over
a four-year period.
CiteScore Best Quartile†:
the journal’s highest CiteScore ranking in a Scopus subject category. Q1
= 25% of journals with the highest CiteScores.
SNIP
(Source Normalized Impact per Paper):
the number of citations per paper in the journal, divided by citation
potential in the field.
SJR
(Scimago Journal Rank):
Average number of (weighted) citations in one year, divided by the
number of articles published in the journal in the previous three years.
Speed/acceptance
From submission to first decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision. Based on manuscripts receiving a
first decision in the last six months.
From submission to first post-review decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision if it is sent out for peer review.
Based on manuscripts receiving a post-review first decision in the last
six months.
From acceptance to online publication:
the average (median) number of days from acceptance of a manuscript to
online publication of the Version of Record. Based on articles published
in the last six months.
Acceptance rate:
articles accepted for publication by the journal in the previous
calendar year as percentage of all papers receiving a final decision.
Daniel J Klionsky - Life Sciences Institute; University of Michigan, Ann Arbor, MI, US
Cancer Section Editor Prof. Jayanta Debnath - UCSF, California, US
Cardiovascular Section Editor Dr Junichi Sadoshima - Rutgers New Jersey Medical School, Newark, US
Virology Section Editor William Jackson - University of Maryland School of Medicine, Baltimore, US
Mitophagy Section Editor Hagai Abeliovich - Hebrew University of Jerusalem, Rehovot, Israel
Neuroscience Section Editor Marta Margeta - USCF School of Medicine, San Francisco, US
Immunology Section Editor Christian Munz - University of Zurich, Zürich, CH
Metabolism Section Editor Wen-Xing Ding - University of Kansas Medical Center, Kansas City, US
Signaling Section Editor Do-Hyung Kim - University of Minnesota, Minneapolis, US
Membrane Biogenesis and Trafficking Section Editor Nicholas Ktistakis - Babraham Institute, Babraham, UK
Bacterial Infection Section Editor Isabelle Vergne - University of Toulouse III, Toulouse, France
Plants Section Editor Daniel Hofius; Swedish University of Agricultural Sciences, Uppsala, Sweden
Associate Editors Ravi Amaravadi - University of Pennsylvania, Philadelphia, PA, US Eric H. Baehrecke - University of Massachusetts Medical School, Worcester, MA, US Sami J. Barmada - University of Michigan, Ann Arbor, MI Sébastien Besteiro - Université de Montpellier, France Ken Cadwell - New York University School of Medicine, New York, NY, US Qian Cai - The State University of New Jersey, Piscataway, NJ, US Guang-Chao Chen - Academia Sinica, Taipei, Taiwan Santosh Chauhan - Institute of Life Sciences, Bhubaneswar, India Charleen T. Chu, M.D., Ph.D. - University of Pittsburgh School of Medicine, Pittsburgh, PA, US Jayanta Debnath - University of California, San Francisco, San Francisco, CA, US Vojo Deretic - University of New Mexico, New Mexico, NM, US Jörn Dengjel - University of Fribourg, Fribourg, Switzerland Zvulun Elazar - The Weizmann Institute of Science, Rehovot, IL Eeva-Liisa Eskelinen - University of Helsinki, Helsinki, FL David A. Gewirtz - Massey Cancer Center, Richmond, VA, US Devrim Gozuacik - SABANCI University, Istanbul, Turkey Ciro Isidoro - Università del Piemonte Orientale, Novara, IT Gábor Juhasz - Eotvos Lorand University, Budapest, Hungary, HU Masaaki Komatsu - School of Medicine Niigata University, JP Jon Lane - University of Bristol, Bristol, UK Wei Li - Guangzhou Medical University, Marta M. Lipinski - University of Maryland School of Medicine, Baltimore, MD, US Wei Liu - School of Medicine; Zhejiang University, CN Ben Loos - Stellenbosch University, Stellenbosch, SA Jan D. Lünemann - University of Münster, Münster, Germany Shouqing Luo - University of Plymouth, UK Sandra Maday - Perelman School ofMedicine, University of Pennsylvania, PA, US Michael A Mandell - University of New Mexico, Albuquerque, NM, US Craig McCormick - Dalhousie University, Nova Scotia, Canada Noboru Mizushima - University of Tokyo, Tokyo, JP Serge Mostowy - Imperial College London, London, UK Rushika Perera - University of California, San Francisco, CA, USA Fulvio Reggiori - University of Groningen, NL Sebastiano Sciarretta - University of Rome "Sapienza", Latina, Italy Han-Ming Shen - National University of Singapore, Singapore Debasish Sinha - University of Pittsburgh School of Medicine, Pittsburgh, US Daolin Tang University of Texas Southwestern, Dallas, TX, US Michael Thumm - Georg August University, Goettingen, DE Roberto Towns - University of Michigan Medical School, Michigan, USA Andrey S. Tsvetkov - The University of Texas McGovern Medical School at Houston, Houston, TX, US Thomas Vaccari - Università degli Studi di Milano, Milano, Italy Zhenyu Yue - Icahn School of Medicine at Mount Sinai, NY, US Simon Wilkinson - The University of Edinburgh, Edinburgh, UK Hong Zhang - Institute of Biophysics, Chinese Academy of Sciences, Beijing, CN Jianhua Zhang - University of Alabama at Birmingham, AL, US
Abstracting and indexing
Autophagy is abstracted/indexed in:
Adis International Ltd. - Reactions Weekly (Online)
EBSCOhost - Biological Abstracts (Online)
Elsevier BV - EMBASE - Scopus
National Library of Medicine - PubMed
Thomson Reuters - Biological Abstracts (Online) - BIOSIS Previews - Science Citation Index Expanded - Web of Science
U.S. National Library of Medicine - MEDLINE
Open access
Autophagy is a hybrid open access journal that is part of our Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
Increase the discoverability and readership of your article
Make an impact and reach new readers, not just those with easy access to a research library
Freely share your work with anyone, anywhere
Comply with funding mandates and meet the requirements of your institution, employer or funder
Rigorous peer review for every open access article
Article Publishing Charges (APC)
If you choose to publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis.
Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors, make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .
Ready to submit?
Start a new submission or continue a submission in progress
![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/110803/Subject-Sample-2021-Bioscience.jpg"})